131 related articles for article (PubMed ID: 26826569)
1. Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.
Parra A; Clares B; Rosselló A; Garduño-Ramírez ML; Abrego G; García ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):10-7. PubMed ID: 26826569
[TBL] [Abstract][Full Text] [Related]
2. Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Vega E; Egea MA; Garduño-Ramírez ML; García ML; Sánchez E; Espina M; Calpena AC
Colloids Surf B Biointerfaces; 2013 Oct; 110():339-46. PubMed ID: 23743255
[TBL] [Abstract][Full Text] [Related]
3. Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications.
Parra A; Mallandrich M; Clares B; Egea MA; Espina M; García ML; Calpena AC
Colloids Surf B Biointerfaces; 2015 Dec; 136():935-43. PubMed ID: 26551871
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Garduño ML; Garcia ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):350-61. PubMed ID: 26844786
[TBL] [Abstract][Full Text] [Related]
5. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Vega E; Egea MA; Calpena AC; Espina M; García ML
Int J Nanomedicine; 2012; 7():1357-71. PubMed ID: 22457594
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
Silva CO; Rijo P; Molpeceres J; Figueiredo IV; Ascensão L; Fernandes AS; Roberto A; Reis CP
Int J Pharm; 2015 Sep; 493(1-2):271-84. PubMed ID: 26222745
[TBL] [Abstract][Full Text] [Related]
7. Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin.
Conte C; Costabile G; d'Angelo I; Pannico M; Musto P; Grassia G; Ialenti A; Tirino P; Miro A; Ungaro F; Quaglia F
J Colloid Interface Sci; 2015 Sep; 454():112-20. PubMed ID: 26004575
[TBL] [Abstract][Full Text] [Related]
8. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
10. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa.
Domínguez-Villegas V; Clares-Naveros B; García-López ML; Calpena-Campmany AC; Bustos-Zagal P; Garduño-Ramírez ML
Colloids Surf B Biointerfaces; 2014 Apr; 116():183-92. PubMed ID: 24463153
[TBL] [Abstract][Full Text] [Related]
12. Ex Vivo Permeation of Carprofen Vehiculated by PLGA Nanoparticles through Porcine Mucous Membranes and Ophthalmic Tissues.
Gómez-Segura L; Parra A; Calpena-Campmany AC; Gimeno Á; Gómez de Aranda I; Boix-Montañes A
Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32085577
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tendon restoration effects of anti-inflammatory, lactoferrin-immobilized, heparin-polymeric nanoparticles in an Achilles tendinitis rat model.
Choi HJ; Choi S; Kim JG; Song MH; Shim KS; Lim YM; Kim HJ; Park K; Kim SE
Carbohydr Polym; 2020 Aug; 241():116284. PubMed ID: 32507170
[TBL] [Abstract][Full Text] [Related]
14. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
Boisgard AS; Lamrayah M; Dzikowski M; Salmon D; Kirilov P; Primard C; Pirot F; Fromy B; Verrier B
Eur J Pharm Biopharm; 2017 Jul; 116():51-60. PubMed ID: 27702687
[TBL] [Abstract][Full Text] [Related]
15. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
Gao H; Wang YN; Fan YG; Ma JB
J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
[TBL] [Abstract][Full Text] [Related]
16. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits.
Musumeci T; Bucolo C; Carbone C; Pignatello R; Drago F; Puglisi G
Int J Pharm; 2013 Jan; 440(2):135-40. PubMed ID: 23078856
[TBL] [Abstract][Full Text] [Related]
18. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles.
Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E
Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338
[TBL] [Abstract][Full Text] [Related]
19. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
20. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
